Wide Ranks

BDX

Becton, Dickinson and Company

221.98

Top Statistics
Market Cap 64 B Forward PE 14.21 Revenue Growth 6.90 %
Current Ratio 1.85 Trailing PE 37.88 Earnings Growth 290.10 %
Profit Margins 7.13 % Peg Ratio Dividend Yield 1.75 %
Enterprice / EBITA 16.07 Enterprise / Revenue 4.14 Price To Sales Trailing12 Months 3.24
Profitability
Profit Margins 7.13 % Operating Margins 15.19 %
Balance Sheet
Total Cash 2 B Total Cash Per Share 7.48 Total Debt 20 B
Total Debt To Equity 77.61 Current Ratio 1.85 Book Value Per Share 89.47
All Measures
Return On Equity 0.0563 Total Debt 20 B Beta 0.4500
Last Split Date 1 B Fifty Two Week Low 218.75 Audit Risk 7
Target Mean Price 281.10 Short Percent Of Float 0.0073 Trailing Peg Ratio 101.60 %
Last Fiscal Year End 1 B Average Volume10days 1 M Next Fiscal Year End 1 B
Held Percent Insiders 0.0028 Ebitda Margins 25.77 % Trailing PE 37.88
Most Recent Quarter 1 B Gmt Off Set Milliseconds -18000000 Fifty Day Average 234.65
Open 224.25 State NJ Return On Assets 0.0325
Time Zone Short Name EST Board Risk 4 Trailing Eps 5.86
Day Low 220.38 Shares Outstanding 289 M Compensation Risk 6
Price Hint 2 Website https://www.bd.com 52 Week Change -0.0601
Recommendation Key buy Quick Ratio 119.70 % Last Split Factor 1025:1000
Is_sp_500 True Profit Margins 7.13 % Debt To Equity 77.61
Fifty Two Week High 249.89 Enterprise To Revenue 4.14 Operating Cashflow 3 B
Five Year Avg Dividend Yield 138.00 % Market Cap 64 B Quote Type EQUITY
Industry Medical Instruments & Supplies Ex Dividend Date 1 B Overall Risk 3
Long Name Becton, Dickinson and Company Current Ratio 1.85 Number Of Analyst Opinions 16
Governance Epoch Date 1 B Forward PE 14.21 Regular Market Volume 2 M
Short Ratio 142.00 % Message Board Id finmb_103678 Shares Short Prior Month 2 M
City Franklin Lakes Uuid 18c79e90-56db-3068-bad2-0c3db8017d8f Previous Close 224.25
First Trade Date Epoch Utc 99 M Book Value 89.47 Volume 2 M
Price To Book 2.48 Total Cash Per Share 7.48 Total Revenue 19 B
Shares Short Previous Month Date 1 B Target Median Price 275.00 Max Age 86400
Recommendation Mean 1.67 Sand P52 Week Change 0.3133 Operating Margins 15.19 %
Last Dividend Value 0.9500 Net Income To Common 1 B Ask 221.30
Implied Shares Outstanding 289 M Average Daily Volume10 Day 1 M Total Cash 2 B
Revenue Per Share 68.37 Dividend Rate 3.89 Date Short Interest 1 B
Share Holder Rights Risk 1 Regular Market Previous Close 224.25 Target Low Price 249.98
Free Cashflow 4 B Dividend Yield 1.75 % Target High Price 327.54
Address1 1 Becton Drive Average Volume 1 M Earnings Quarterly Growth 289.80 %
Forward Eps 15.73 Compensation As Of Epoch Date 1 B Regular Market Day High 226.67
Day High 226.67 Shares Short 2 M Regular Market Open 224.25
Industry Key medical-instruments-supplies Bid 221.30 Earnings Growth 290.10 %
Revenue Growth 6.90 % Shares Percent Shares Out 0.0073 Currency USD
Time Zone Full Name America/New_York Is_nasdaq_100 False Zip 07417-1880
Payout Ratio 64.85 % Regular Market Day Low 220.38 Held Percent Institutions 0.9175
Current Price 221.98 Enterprise To Ebitda 16.07 Financial Currency USD
Gross Margins 44.90 % Industry Disp Medical Instruments & Supplies Country United States
Float Shares 288 M Two Hundred Day Average 235.61 Ir Website http://www.bd.com/investors/
Enterprise Value 82 B Price To Sales Trailing12 Months 3.24 Last Dividend Date 1 B
Ebitda 5 B Exchange NYQ
Go to Yahoo Finance Go to Seeking Alpha 
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide.

The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.

The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems.

The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers.

The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products.

The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.